Aethlon Competitors
| AEMD Stock | USD 2.09 0.11 5.00% |
Aethlon Medical vs Vivos Therapeutics Correlation
Poor diversification
The correlation between Aethlon Medical and VVOS is 0.67 (i.e., Poor diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Aethlon Medical and VVOS in the same portfolio, assuming nothing else is changed.
Moving together with Aethlon Stock
Moving against Aethlon Stock
| 0.91 | QIPT | Quipt Home Medical | PairCorr |
| 0.84 | VMD | Viemed Healthcare | PairCorr |
| 0.82 | 4DX | 4DMEDICAL | PairCorr |
| 0.52 | AMS | Advanced Medical Sol | PairCorr |
Aethlon Medical Competition Correlation Matrix
Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Aethlon Medical and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Aethlon and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Aethlon Medical does not affect the price movement of the other competitor.
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Aethlon Stock performing well and Aethlon Medical Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Aethlon Medical's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| CODX | 5.94 | (1.80) | 0.00 | (0.80) | 0.00 | 9.88 | 75.41 | |||
| ALUR | 5.94 | (0.63) | 0.00 | (0.09) | 0.00 | 16.54 | 40.95 | |||
| NVNO | 5.66 | (1.29) | 0.00 | (0.44) | 0.00 | 8.99 | 41.30 | |||
| ERNA | 5.23 | (2.05) | 0.00 | 4.90 | 0.00 | 6.90 | 59.74 | |||
| ADAP | 12.64 | 0.62 | 0.03 | (1.50) | 15.04 | 22.82 | 168.52 | |||
| XAIR | 7.39 | 0.46 | 0.02 | (0.09) | 6.24 | 14.46 | 163.02 | |||
| TNON | 3.03 | (0.61) | 0.00 | (0.46) | 0.00 | 6.38 | 18.03 | |||
| IINN | 3.48 | (0.50) | 0.00 | (0.54) | 0.00 | 7.29 | 24.08 | |||
| LNAI | 6.36 | 0.27 | 0.02 | (0.21) | 5.84 | 19.44 | 44.27 | |||
| VVOS | 3.41 | (0.52) | 0.00 | (0.36) | 0.00 | 7.18 | 31.84 |
Cross Equities Net Income Analysis
Compare Aethlon Medical and related stocks such as Co Diagnostics, Allurion Technologies, and enVVeno Medical Corp Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CODX | (1 M) | (1 M) | (1 M) | (1 M) | (1 M) | (2 M) | (1.9 M) | (7 M) | (6.3 M) | (6.2 M) | 42.5 M | 36.7 M | (14.2 M) | (35.3 M) | (37.6 M) | (33.9 M) | (32.2 M) |
| ALUR | (5.2 K) | (5.2 K) | (5.2 K) | (5.2 K) | (5.2 K) | (5.2 K) | (5.2 K) | (5.2 K) | (5.2 K) | (5.2 K) | (5.2 K) | (12.4 M) | (37.7 M) | (80.6 M) | (26.1 M) | (23.5 M) | (24.7 M) |
| NVNO | (1.4 M) | (1.4 M) | (1.4 M) | (1.4 M) | (1.4 M) | (1.6 M) | (5.9 M) | (7.8 M) | (13 M) | (7.6 M) | (9.1 M) | (16.5 M) | (24.7 M) | (23.5 M) | (21.8 M) | (19.6 M) | (18.7 M) |
| ERNA | (4.8 M) | (3.4 M) | (995 K) | (1.1 M) | (5 M) | (7.2 M) | (2.9 M) | (1.1 M) | (259 K) | (2 M) | 11.9 M | (122.5 M) | (24.6 M) | (21.7 M) | (44.5 M) | (40.1 M) | (38.1 M) |
| XAIR | (1.6 M) | (1.6 M) | (1.6 M) | (1.6 M) | (4.8 M) | (3.7 M) | (29.7 K) | (18 M) | (6.6 M) | (19.9 M) | (22.9 M) | (43.2 M) | (55.8 M) | (60.2 M) | (46.6 M) | (42 M) | (39.9 M) |
| TNON | (509.6 K) | (509.6 K) | (509.6 K) | (509.6 K) | (509.6 K) | (509.6 K) | (509.6 K) | (509.6 K) | (509.6 K) | (509.6 K) | (585.2 K) | (7 M) | (18.9 M) | (15.6 M) | (13.7 M) | (12.3 M) | (12.9 M) |
| IINN | (39.6 K) | (39.6 K) | (39.6 K) | (39.6 K) | (39.6 K) | (39.6 K) | (39.6 K) | (39.6 K) | (39.6 K) | (4.6 M) | (7.2 M) | (17 M) | (4 M) | (11.3 M) | (11.1 K) | (9.9 K) | (10.4 K) |
| LNAI | (26.7 M) | (26.7 M) | (26.7 M) | (26.7 M) | (26.7 M) | (26.7 M) | (26.7 M) | (26.7 M) | (26.7 M) | (26.7 M) | (26.7 M) | (113.4 M) | (39.7 M) | (88.4 M) | (178 M) | (160.2 M) | (152.2 M) |
| VVOS | (8.5 M) | (8.5 M) | (8.5 M) | (8.5 M) | (8.5 M) | (8.5 M) | (8.5 M) | (8.5 M) | (8.5 M) | (10.8 M) | (12.1 M) | (20.3 M) | (23.8 M) | (13.6 M) | (11.1 M) | (10 M) | (10.5 M) |
Aethlon Medical and related stocks such as Co Diagnostics, Allurion Technologies, and enVVeno Medical Corp Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Aethlon Medical financial statement analysis. It represents the amount of money remaining after all of Aethlon Medical operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Aethlon Medical Competitive Analysis
The better you understand Aethlon Medical competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Aethlon Medical's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Aethlon Medical's competition over several years is one of the best ways to analyze its investment potential.| Better Than Average | Worse Than Peers | View Performance Chart |
Aethlon Medical Competition Performance Charts
Five steps to successful analysis of Aethlon Medical Competition
Aethlon Medical's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Aethlon Medical in relation to its competition. Aethlon Medical's competition analysis typically involves several steps, including:- Identifying the key players in the market: This involves identifying the major competitors of Aethlon Medical in the market, both direct and indirect, as well as new entrants and disruptive technologies.
- Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
- Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Aethlon Medical's competitive landscape.
- Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Aethlon Medical, and developing a strategy to address them.
- Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Complement your Aethlon Medical position
In addition to having Aethlon Medical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Consumer Discretionary ETFs Thematic Idea Now
Consumer Discretionary ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Consumer Discretionary ETFs theme has 32 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Consumer Discretionary ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Aethlon Medical Correlation with its peers. For information on how to trade Aethlon Stock refer to our How to Trade Aethlon Stock guide.You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Will Health Care Equipment & Supplies sector continue expanding? Could Aethlon diversify its offerings? Factors like these will boost the valuation of Aethlon Medical. If investors know Aethlon will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Aethlon Medical data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share 207.32 | Revenue Per Share | Quarterly Revenue Growth 42.782 | Return On Assets | Return On Equity |
Aethlon Medical's market price often diverges from its book value, the accounting figure shown on Aethlon's balance sheet. Smart investors calculate Aethlon Medical's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Aethlon Medical's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Understanding that Aethlon Medical's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Aethlon Medical represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. However, Aethlon Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.